Company intelligence / Profile preview
Hefei HankeMab Biotechnology
Hefei, Anhui, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Pipeline includes novel monoclonal and bispecific antibodies, with lead assets in Phase 1 and Phase 2 targeting cancer including non-Hodgkin lymphoma and HER2-positive gastric cancer. ZG033, a 4-1BB agonist mAb, received NMPA IND approval in 2024 and is in Phase 1. Recombinant anti-HER2 humanized HuA21 mAb is in Phase 2 for HER2-positive cancers. Bispecific candidates and fusion proteins are in preclinical and clinical evaluation, spanning hematologic and solid tumor indications. Most programs are in early- to mid-stage clinical development with no reported pivotal trial results yet.[2][3]
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyBispecific antibodyAntibody fusion proteins
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Zencore Biologics
Beyond the preview
Go deeper on Hefei HankeMab Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hefei HankeMab Biotechnology.